Physician profile
Amit Vira
NPI 1740676600
$6,132.04
in general payments reported to CMS, 2019-2025
15 companies · $93.05 in 2025
The $93.05 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,622 · 2022: $588 · 2023: $559 · 2024: $3,271 · 2025: $93.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,191 · Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,191.43 |
| Food and Beverage | $1,731.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,629.15 | 2021-2025 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Boston Scientific Corporation | $613.67 | 2021-2025 | Synergy, Rotapro |
| Inari Medical, INC. | $545.30 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $488.14 | 2021-2023 | Perclose Prostyle |
| Opsens INC. | $178.47 | 2022 | |
| Abiomed | $171.63 | 2021-2023 | Impella |
| Cardiovascular Systems INC. | $139.88 | 2021 | |
| Philips North America LLC | $108.69 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $90.79 | 2024-2025 | Camzyos, Eliquis |
| Pfizer INC. | $47.36 | 2024 | |
| Terumo Medical Corporation | $29.00 | 2023 | Angio-Seal, Glidesheath Slender |
| Corcept Therapeutics | $26.94 | 2025 | Korlym |
| Novo Nordisk INC | $25.48 | 2024 | Wegovy |
| Novartis Pharmaceuticals Corporation | $20.83 | 2024 | |
| Penumbra, INC. | $16.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Vira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.